| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $17.4M | +53.2% |
| R&D Expense | $4.8M | +63.0% |
| SG&A Expense | $11.9M | +39.3% |
| Operating Income | -$10.8M | -81.1% |
| Interest Expense | $236K | +362.7% |
| Pre-tax Income | -$6.8M | -12.4% |
| Income Tax | $109K | +108.7% |
| Net Income | -$6.5M | -2310.1% |
| EPS (Basic) | -$0.15 | -1600.0% |
| EPS (Diluted) | -$0.15 | -1600.0% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.9M | +310.3% |
| Accounts Receivable | $3.8M | +30.5% |
| Current Assets | $15.1M | +106.7% |
| Total Assets | $61.8M | +138.0% |
| Current Liabilities | $13.5M | +83.2% |
| Long-term Debt | $9.9M | +330.4% |
| Total Liabilities | $27.8M | +227.2% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $41K | -6.8% |
| Investing Cash Flow | -$13.2M | -239.2% |
| Financing Cash Flow | $24.1M | +920.6% |
| Stockholders' Equity |
| $34.0M |
| +94.7% |